Long Island New York OBGYN Front Photo


The Sexy Years, Suzanne Somers

Natural hormones VS. Synthetic hormones

Somers explains how she's coped with the symptoms of menopause and why she believes most women should take natural hormones during this period. Somers discusses her breast cancer surgery, along with her decision not to undergo certain follow-up treatment but instead adhere to a regimen of natural hormones.

To support her case, Somers includes interviews with several physicians who specialize in natural hormones, sexual dysfunction and menopause. Her enthusiastic writing style will especially appeal to readers who have been intimidated by physicians unwilling to offer alternative treatments to menopause's often debilitating symptoms.
Somers stresses the important steps of the process, and discusses reasons why she prefers natural hormones over synthetic substances. As an introduction to the subject of alternative treatments for menopause, this book provides a sound synopsis that readers can use to open a dialogue with their physicians.
- Publishers Weekly

Health Cast Channel 7 News Boston:

Ovulation Predictor
"As you approach ovulation the estrogen level in your body increases. This then increases the salt content in the saliva. So when you place the saliva on the microscope slide under the microscope and it dries you can see a crystallized salt pattern called a fern pattern," says Anita Sadaty, M.D., attending physician in Obstetrics and Gynecology at North Shore University Hospital in Manhasset, New York.


» Women's Health Initiative
» WHI Memory Study (WHIMS)
» FDA statement on postmenopausal hormone therapy
» Postmenopausal hormone therapy
» Menopausal hormone therapy information
» The Sexy Years, Suzanne Somers

This web site does not provide medical advice, diagnosis or treatment.
The contents of this site, such as text, graphics, images, and other material contained on the Long Island New York OBGYN Site ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Long Island New York OBGYN site!

If you think you may have a medical emergency, call your doctor or 911 immediately.

Bioidentical Hormone Replacement

In her book, The Sexy Years, Suzanne Somers has made the term "bioidentical hormones" a household word. In this book she describes the positive impact of bioidentical hormones on her life in relieving menopausal symptoms despite warnings against using them given her history of breast cancer. What are bio-identical hormones and what is their role in hormone replacement therapy?

What exactly is bioidentical hormone?

Bioidentical hormonesBioidentical hormones (BH) are hormones that are made with the exact same molecular structure as those hormones naturally produced in our body. This has nothing to do with whether or not they are made from "yams" or are "natural" - rather it means that they are manufactured as the identical chemical structure produced in the human body. Many other types of synthetic hormones are made intentionally different so that the drug company can obtain a patent on a novel structure. Currently many drug companies have caught on to the appeal that BH's have for a growing number of women in the United States, and there are certain formulations that are "bio-identical." Nevertheless, it is important to individualize therapy to achieve maximum symptom relief at the lowest dose possible.

Are bioidentical hormones better for you than the synthetic type?

Although it makes logical sense that the human body would react better to BH's and that the metabolism of these products would be superior compared to non-identical hormone products, there is very little data to support this claim. The largest study to date, the Women's Health Initiative, conducted a study comparing the risks and benefits of hormone replacement therapy in thousands of women. This study was based on synthetic hormones and thus the results may not necessarily apply to use with BH's, however, most researchers and medical professionals warn that the adverse effects must be assumed to apply to BH's as well.

WHI Study

The Women's Health Initiative is one of the largest US prevention studies designed to look at the effects of Hormone replacement therapy (HT), diet modification, and vitamin and mineral supplements. Over 16,000 women were involved in the HT arm of the study and after nearly 6 years, the study made the following conclusions:

What were the risks of using HT?

For every 10,000 women taking Prempro (the synthetic hormone preparation used in the study) each year:

What were the benefits?

For every 10,000 women taking Prempro there would be:

Prior to the WHI study in 2002, most studies of hormone therapy (HT) in postmenopausal women showed that it had a positive effect on heart disease. The WHI study was designed to be a placebo-controlled, prospective, randomized trial that would definitively establish the value of HT in the treatment of post-menopausal women. The conclusions of the study, contrary to expectations, showed small increases in both cardiovascular disease and breast cancer among the women in the HT treatment groups.

Many physicians began to counsel their patients to stop their HT regimens as a result of this study, stating that HT was placing them at increased risk for heart disease and breast cancer. Many women were put in the position of either stopping their HT and living with the uncomfortable symptoms of menopause, or staying on HT potentially increasing the risk of developing a serious medical condition.

Dr. Leonard Rogatis, PhD, wrote an interesting review of the study conclusions. He noted that once medical professionals and researchers began reviewing the conclusions of the report and the design of the WHI study, there appeared to be some flaws that put into question many of the recommendations against the use of HT in post-menopausal women.

Some of the flaws in the study design include the following:

  1. the women in the study were disproportionately older (63 years) than the age of women who typically enter menopause (51 years);
  2. these women had never been on any type of hormone regimen prior to the study
  3. the particular HT regimen chosen to be used by the study participants had never been demonstrated to prevent cardiovascular disease in previous studies that did show cardiovascular benefit.

He concluded that these facts may not change the findings of the WHI study, but they render the findings much less relevant for most postmenopausal women.